RCAG
BSX icon

Rehmann Capital Advisory Group’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$631K Buy
5,878
+311
+6% +$33.4K 0.04% 306
2025
Q1
$562K Buy
5,567
+322
+6% +$32.5K 0.04% 333
2024
Q4
$468K Buy
5,245
+339
+7% +$30.3K 0.03% 368
2024
Q3
$415K Sell
4,906
-7
-0.1% -$592 0.03% 381
2024
Q2
$378K Buy
4,913
+120
+3% +$9.24K 0.03% 393
2024
Q1
$328K Sell
4,793
-256
-5% -$17.5K 0.02% 427
2023
Q4
$292K Buy
5,049
+58
+1% +$3.35K 0.02% 440
2023
Q3
$264K Sell
4,991
-165
-3% -$8.71K 0.02% 428
2023
Q2
$279K Buy
5,156
+129
+3% +$6.98K 0.03% 441
2023
Q1
$252K Buy
5,027
+379
+8% +$19K 0.02% 462
2022
Q4
$215K Buy
+4,648
New +$215K 0.02% 504
2020
Q3
Sell
-9,829
Closed -$345K 428
2020
Q2
$345K Buy
9,829
+2,190
+29% +$76.9K 0.05% 300
2020
Q1
$249K Buy
+7,639
New +$249K 0.04% 327
2019
Q3
$415K Sell
10,194
-3,582
-26% -$146K 0.05% 188
2019
Q2
$592K Sell
13,776
-37
-0.3% -$1.59K 0.07% 217
2019
Q1
$530K Buy
13,813
+179
+1% +$6.87K 0.07% 207
2018
Q4
$482K Buy
13,634
+665
+5% +$23.5K 0.07% 139
2018
Q3
$499K Buy
12,969
+995
+8% +$38.3K 0.07% 212
2018
Q2
$392K Sell
11,974
-2,206
-16% -$72.1K 0.06% 246
2018
Q1
$387K Buy
14,180
+2,853
+25% +$77.9K 0.06% 232
2017
Q4
$281K Sell
11,327
-804
-7% -$19.9K 0.05% 293
2017
Q3
$354K Buy
12,131
+3,432
+39% +$100K 0.06% 236
2017
Q2
$241K Buy
+8,699
New +$241K 0.05% 304
2016
Q4
Sell
-13,320
Closed -$317K 385
2016
Q3
$317K Buy
13,320
+1,824
+16% +$43.4K 0.06% 248
2016
Q2
$269K Buy
11,496
+211
+2% +$4.94K 0.05% 277
2016
Q1
$212K Sell
11,285
-4,171
-27% -$78.4K 0.04% 319
2015
Q4
$285K Sell
15,456
-55
-0.4% -$1.01K 0.06% 238
2015
Q3
$255K Sell
15,511
-1,171
-7% -$19.3K 0.06% 254
2015
Q2
$295K Sell
16,682
-694
-4% -$12.3K 0.07% 226
2015
Q1
$308K Buy
17,376
+618
+4% +$11K 0.07% 232
2014
Q4
$222K Buy
+16,758
New +$222K 0.05% 296